Sponsor Quotes

“The pandemic has shown the truth of the statement “the cost is billions, but the return is trillions,” since without prior robust investments in NIH, life-saving vaccines would not have been developed so quickly.  The President recognized this by requesting an historic increase for NIH.  To continue NIH’s life-saving research, we have pressed for a 10% ($4.3B) increase in NIH in FY22 – to help us not only prepare for the next pandemic, but also to pursue the historic number of life-saving research proposals being submitted to NIH every day.  We’re excited by the House mark, which increased NIH by an impressive $3.5B, and urge the Senate to exceed the largest increase that has ever been provided for NIH, which was $3.84B in 2003 – and make history.”

Richard Turman
President, ACT for NIH: Advancing Cures Today

The scientific community’s unprecedented innovation during the pandemic — across vaccines, diagnostic testing, and therapeutics – was made possible on the foundation of decades of NIH-funded research.Congress must prioritize support for the NIH to fuel the advances that will improve public health and outcomes for patients today and in the future.

Lance Baldo, MD
Chief Medical Officer, Adaptive Biotechnologies

“This is a very hopeful moment for people living with Alzheimer’s and their families due to unprecedented Alzheimer’s and dementia research funding. The federal commitment, combined with philanthropic support, provides the foundation for an optimistic view of the future — which is needed, because there is much work to be done.”

Rachel Conant
Vice President, Federal Affairs, Alzheimer’s Association


“Thanks to the extraordinary bipartisan leadership of our champions in Congress, the NIH has received significant funding increases over the last six fiscal years. These investments are enabling us to make new discoveries related to the prevention, early detection, diagnosis, and treatment of many types of cancer. Further advances will depend on sustained funding increases for the NIH. The Rally for Medical Research Hill Day is an important opportunity to speak with one voice about the value of NIH-supported research for cancer and hundreds of other diseases.”

David A. Tuveson, MD, PhD, FAACR
President, American Association for Cancer Research


“The National Institute of Nursing Research is on the frontlines of establishing the science that improves practice and policy. Nursing scientists focus on patient and community centered advances that translate to direct cost savings to the healthcare system, patients, and communities. Sustained and increased funding for biomedical and behavioral research is critical to supporting scientific discoveries that promote better health and wellness.”

Deborah Trautman, PhD, RN, FAAN
President and Chief Executive Officer, American Association of Colleges of Nursing


“The COVID-19 pandemic has highlighted the essential role of immunological research in the prevention and treatment of disease. Understanding the immune response to mRNA and viral vector vaccines – as well as to potential therapeutics – directly led to the rapid development of the safe, life-saving vaccines and treatments for COVID-19 that we have today. Immunological advances have also led to the development of safe, effective vaccines and/or therapeutics for other infectious and chronic diseases, including influenza, cancer, and rheumatoid arthritis. None of this would have been possible without decades of fundamental immunological research supported by the National Institutes of Health (NIH). Continued, robust NIH funding is urgently needed to support immunological research on the basic biology, prevention, and treatment of these and many other chronic and infectious diseases.”

Gary Koretzky, MD, PhD
President, American Association of Immunologists


“Physiologists study how the body responds to many types of stimuli, including stress from disease. In just the past few decades, discoveries in physiology have been leveraged to advance human health. Funding from the NIH provides the foundation for these critical discoveries by supporting researchers and training the next generation of creative and innovative physiologists who will sustain the legacy of US leadership in medical research.”

Jennifer Pollock, PhD, FAPS
President, American Physiological Society


“The missing ingredient between medical breakthroughs and improved patient health is behavioral science.  The discipline of psychology aims to understand the psychological risks for physical and mental symptoms, as well as the social, cultural, and psychological factors that guide people’s health behavior decisions. APA is pleased to join with other scientific associations to urge Congress to provide the National Institutes of Health (NIH) with substantial increases in funding so that all science can be used to promote physical and behavioral wellness, reduce health disparities, and guide the US through the pandemic crises.”

Mitch Prinstein, PhD, ABPP 
Chief Science Officer, American Psychological Association


“NIH’s investment in biomedical research is essential not only to advancing our understanding of public health crises like the COVID-19 pandemic, but also to advancing the development of cutting-edge treatments for sickle cell disease, blood cancers, and other serious blood disorders.”

Martin S. Tallman, MD
President, American Society of Hematology (ASH)


“NIH-funded research has demonstrated how human genetics and genomics advances scientific discovery and improves human health. A commitment to health equity in genomics is crucial for all people to realize the benefits of this research.  Sustained budget increases for NIH are necessary to fund programs that emphasize diversity and equity in the workforce and that broaden participation by the public in research.”

Gail Jarvik, MD, PhD
President, American Society of Human Genetics


“We have made tremendous progress against cancer in the past 50 years since the National Cancer Act was first signed into law, but even during a global pandemic, cancer remains the second most common cause of death in the United States. There’s still an incredible amount of work to do to achieve our vision of a world where every cancer is prevented or cured, and every survivor is healthy. Meeting this vision requires a renewed national dedication to confronting cancer. We are fortunate to live in a time when our cancer research community is flourishing with new ideas to conquer cancer. Now, we need Congress to match our enthusiasm and provide an increase in federal funding so that we can continue to keep up with the pace of scientific opportunity and make progress against cancer.”

Howard A. “Skip” Burris III, MD, FACP, FASCO
Chair of the Board, Association for Clinical Oncology


“AACI’s mission is to accelerate progress against cancer. After a year and a half in which this progress was disrupted due to the COVID pandemic, it is imperative to keep moving cancer research forward. A bipartisan commitment to robust funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI) is key to progress; and stable, predictable funding increases are key to the success of AACI’s 103 member cancer centers. Funding from the NIH and NCI drive the lifesaving discoveries and high quality care these cancer centers are known for.”

Jennifer W. Pegher
Executive Director, Association of American Cancer Institutes


“People everywhere rely on the NIH and the medical research it supports nationwide for the promise of a healthier tomorrow. As leading centers of medical research that conduct over 50% of NIH-supported extramural research, the nation’s academic medical centers continue to conduct critical work to combat COVID-19, other health threats, and diseases. This work includes the development of vaccines and therapeutics, as well as improved testing, other diagnostics, and patient care. Sustained funding growth for the NIH is vital to ensure that cutting-edge and life-saving medical research in all areas – and for a range of illnesses, conditions, and scientific disciplines – expands and continues.”

David J. Skorton, MD
President and CEO, Association of American Medical Colleges


“Biomedical research is vital to our health and well-being and brings precious hope to patients with cancer and the community. Our work-force has stepped up during COVID and continued to make research breakthroughs in the fight against cancer. There are many opportunities to make a difference, through discoveries, by inspiring the next generation of scientists and physician researchers, and by impacting on health disparities. Our mission here at the Cancer Center at Brown University is to improve the lives of patients in Rhode Island and throughout the world.”

Wafik S. El-Deiry, MD, PhD, FACP
Director, Cancer Center at Brown University
Associate Dean, Oncologic Sciences, Warren Alpert Medical School, Brown University


“I am a gastroenterologist by training and have spent a good part of my career doing cancer research and treating at risk cancer patients. Over the past two decades or so, we have made tremendous strides in the effort to better understand, prevent, and treat cancer. I can say that, almost without exception, none of this would have been possible were it not for the National Institutes of Health (NIH). Virtually every drug, every test, every diagnostic tool, every new technology, every prevention strategy that we use in the fight against cancer can trace its roots back to NIH funding.  Please take a moment to think about a friend or relative who has survived cancer and is living a normal active life. Know that if it were not for biomedical research funded by the NIH, there is a good chance that person may not still be with us. This is not limited to cancer.  Think about someone who has Alzheimer’s disease, or a heart condition, or who is dealing with a mental illness. What are our best chances for preventing and developing treatments for those conditions, so patients and families will no longer have to suffer as much? There is a pretty good chance it involves the NIH.”

Anil K. Rustgi, MD 
Interim Executive Vice President and Dean of the Faculties of Health Sciences and Medicine, Columbia University
Irving Medical Center


“We have an opportunity now to accelerate our progress against many cancers. That’s why strong Congressional support and commitment to cancer research is more crucial now than ever before. Federal investment in research at the NIH, including the NCI, provides the foundation for important discoveries in cancer research and treatment, and has the power to save lives. I am pleased to join my colleagues from across the country in calling on our nation’s policymakers to make funding for the NIH a national priority.”

Laurie H. Glimcher, MD
President and CEO, Dana-Farber Cancer Institute
Richard and Susan Smith Professor of Medicine, Harvard Medical School


“The National Institutes of Health (NIH) remains our nation’s premier biomedical research agency. In order to continue its critical mission to develop new therapies for current, emerging and future health challenges adversely affecting the wellbeing and lives of all Americans, including those disproportionately impacting under-resourced communities and more broadly, disadvantaged global populations, the NIH must have predictable, sustainable, impactful funding for our research enterprise. The NIH’s funding for innovative, reproducible and rigorous basic, translational and clinical research importantly supports biomedical education and training, and research projects leading to significant, new advances in therapeutics and preventative medicine to meet health challenges.”

Patricia L. Morris, MS, PhD
President, Federation of American Societies for Experimental Biology (FASEB)


“This year, Rally for Medical Research participants can voice their support for the $3.5 billion increase in National Institutes of Health (NIH) ‘base’ funding included in the Fiscal Year (FY) 2022 House Labor-HHS bill to ensure inflation-plus-growth increases for the Institutes and Centers. We must stress to both chambers the importance of completing FY2022 appropriations in a timely fashion to avoid Continuing Resolutions that have a chilling impact on research—as the COVID-19 pandemic laboratory closures have already caused a major disruption to research. In that regard, the community should continue to request supplemental funding for NIH to mitigate the impact of these lab closures, which NIH Director Francis Collins, MD, PhD estimated earlier this year at $16 billion.”

James Jorkasky, MBA
Executive Director, National Alliance for Eye and Vision Research (NAEVR) 


“Never has the role of medical research been more critical and immediately apparent. We must sustain and increase investment in NIH to develop solutions not only for crises like the current pandemic, but for all health challenges that affect Americans throughout their lifespan. For diseases like eczema, including atopic dermatitis – which is chronic, heterogeneous and without a cure – hope lies with scientific research to improve the lives of over 31 million Americans.”

Julie Block
President and CEO, National Eczema Association 


“At UCLA Health, NIH-funded research is helping us to better understand the SARS CoV-2 virus, gain insights into the many faceted manifestation of COVID-19 infections, test new COVID-19 treatments and investigate the impact of COVID-19 on at-risk communities.  Continued support for NIH is the best way to protect us during the current pandemic and to invest in the people and infrastructure our country needs to find new treatments and cures for all conditions.”

John Mazziotta, MD, PhD
Vice Chancellor, UCLA Health Sciences
CEO, UCLA Health


“The value of biomedical research has never been more self-evident.  Indeed the hope for our entire world is dependent upon it.”

Roy A. Jensen, MD
Director, The University of Kansas Cancer Center


“Sustained NIH funding and increased funding for new initiatives drive discoveries in oncology and in many other areas vital to our heath. By continuing to apply our knowledge of cancer biology, bioinformatics, viral oncology and population science, we can positively influence the health of our nation. The last several months of the global pandemic have shown that such funding is critical in sustaining the health and safety of our population, including racial and ethnic minority communities, rural communities and underserved communities.”

Alan E. Tomkinson, PhD
Interim Director and Chief Executive Officer, The University of New Mexico Comprehensive Cancer Center


“The COVID-19 pandemic has laid bare the health challenges our nation faces. Strong federal investments in biomedical research, specifically at the NIH, have helped the academic medical community identify treatments and interventions for COVID-19. Yet due to the public health crisis, investigation into other disease types, such as cancer and Alzheimer’s has slowed significantly. Now is the time for Congress to double-down on investments in lifesaving research.”